MIND Neuroscience Prize supports early-to-mid-career investigators pursuing bold brain research to deepen understanding of neurodegenerative diseases and advance their prediction, prevention, and treatment.
Funder: Pershing Square Philanthropies
Due Dates (Anticipated): September 2027 (Letter of Intent)
Funding Amounts: $750,000 over three years ($250,000 annually); at least six prizes awarded annually
Summary: Supports early-to-mid-career investigators pursuing bold neuroscience research to advance understanding, prediction, prevention, and treatment of neurodegenerative diseases.
Key Information: Tool and technology development must support a clearly defined biological hypothesis; proposals should not center on clinical trials.
The MIND (Maximizing Innovation in Neuroscience Discovery) Prize is the Pershing Square Foundation’s brain research initiative. It supports early-to-mid-career investigators pursuing bold, hypothesis-driven, high-risk, high-reward research with potential for transformative impact on neurodegenerative diseases, including Alzheimer’s disease and dementia. The program seeks to deepen fundamental understanding of the brain and cognition while advancing the ability to predict, prevent, and treat these diseases.
The prize encourages interdisciplinary approaches and collaboration across academic departments and institutions. Research may span neurobiology, brain imaging and mapping, machine learning, drug delivery, and synthetic biology, among other domains. Projects can range from new tools for mapping and analyzing the brain to approaches with extraordinary therapeutic potential, linking basic scientific discovery with translational research.